WIRE — FDA resmi menyetujui mFLUSIVA, vaksin flu berbasis mRNA pertama dari Moderna untuk usia 50 tahun ke atas. Simak keunggulan, efikasi, dan jadwal ketersediaannya.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.